Skip to main content
. Author manuscript; available in PMC: 2019 Sep 10.
Published in final edited form as: Regul Pept. 2002 Nov 15;109(1-3):135–140. doi: 10.1016/s0167-0115(02)00196-9

Table 3.

VEGF mRNA

Addition Percentage VEGF mRNA
None 100±8
PACAP-27, 100 nM 194±13 **
VIP, 100 nM 152±11 *
PACAP-27 + PACAP(6–38) 135±14 *
VIP + PACAP(6–38) 157±15 *
PACAP+ 50 µM H89 144±15 *
VIP + H89 112±9
PACAP-27 + 10 µM PD98059 141±12 *
VIP + PD98059 144±9 *

Agents were added to NCI-H1299 cells at the indicated concentrations and the RNA extracted after 8 h. The relative percentage VEGF mRNA (mean ± S.D. of four determinations) is indicated; using Student’s t-test.

*

p < 0.05.

**

p < 0.01.

HHS Vulnerability Disclosure